Hydatiform mole overview

Jump to navigation Jump to search

Hydatiform mole Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hydatiform mole from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hydatiform mole overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hydatiform mole overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hydatiform mole overview

CDC on Hydatiform mole overview

Hydatiform mole overview in the news

Blogs on Hydatiform mole overview

Directions to Hospitals Treating Hydatiform mole

Risk calculators and risk factors for Hydatiform mole overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Hydatidiform mole (or mola hydatidiforma) is a common complication of pregnancy, occurring once in every 1000 pregnancies in the US, with much higher rates in Asia (e.g. up to one in 100 pregnancies in Indonesia). It consists of a nonviable embryo which implants and proliferates within the uterus.[1] The term is derived from hydatidiform ("like a bunch of grapes") and mole (from Latin mola = millstone).

Most moles present with painless vaginal bleeding during the second trimester of pregnancy. They are diagnosed by ultrasound imaging. Extremely high levels of human chorionic gonadotropin (HCG) are suggestive, but not diagnostic, of molar pregnancy.[2] Today moles are surgically removed by curettage, in order to avoid the risks of choriocarcinoma.[3]

References

  1. Robbins and Cotran's Pathological Basis of Disease, 7th ed., p. 1110
  2. McPhee S. and Ganong W.F. Pathophysiology of Disease, 5th ed., p. 639.
  3. Robbins and Cotran's Pathological Basis of Disease, 7th ed., p. 1112